AKT1 and sarcopenia: Furthermore, the observed enrichment also highlighted potential key pathways that could contribute to sarcopenia, such as the PI3K‐Akt signalling pathway, providing clues for future investigations into the mechanisms underlying sarcopenia and identifying effective drug targets.